Alpha Tau Medical Ltd
DRTS3.810USD
-0.030-0.78%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
268.15MMarket Cap
LossP/E TTM
More Details of Alpha Tau Medical Ltd Company
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.
Company Info
Ticker SymbolDRTS
Company nameAlpha Tau Medical Ltd
IPO dateMar 08, 2022
CEOMr. Uzi Sofer
Number of employees125
Security typeOrdinary Share
Fiscal year-endMar 08
AddressKiryat Hamada 5
CityJERUSALEM
Stock exchangeNASDAQ Capital Market Consolidated
CountryIsrael
Postal code9777605
Phone97235774115
Websitehttps://www.alphatau.com/
Ticker SymbolDRTS
IPO dateMar 08, 2022
CEOMr. Uzi Sofer
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Uzi Sofer
Mr. Uzi Sofer
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
11.52M
--
Mr. Michael Avruch
Mr. Michael Avruch
Independent Director
Independent Director
1.55M
+0.17%
Prof. Yona Keisari
Prof. Yona Keisari
Chief Scientific Officer
Chief Scientific Officer
504.27K
+0.16%
Mr. Amnon Gat
Mr. Amnon Gat
Chief Operations Officer
Chief Operations Officer
68.47K
--
Mr. Raphi Levy
Mr. Raphi Levy
Chief Financial Officer
Chief Financial Officer
--
--
Prof. Itzhak Kelson
Prof. Itzhak Kelson
Chief Physics Officer
Chief Physics Officer
--
--
Dr. Robert Den, M.D.
Dr. Robert Den, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Gary Leibler
Mr. Gary Leibler
Independent Director
Independent Director
--
--
Mr. Alan Adler
Mr. Alan Adler
Independent Director
Independent Director
--
--
Dr. S. Morry Blumenfeld, Ph.D.
Dr. S. Morry Blumenfeld, Ph.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Uzi Sofer
Mr. Uzi Sofer
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
11.52M
--
Mr. Michael Avruch
Mr. Michael Avruch
Independent Director
Independent Director
1.55M
+0.17%
Prof. Yona Keisari
Prof. Yona Keisari
Chief Scientific Officer
Chief Scientific Officer
504.27K
+0.16%
Mr. Amnon Gat
Mr. Amnon Gat
Chief Operations Officer
Chief Operations Officer
68.47K
--
Mr. Raphi Levy
Mr. Raphi Levy
Chief Financial Officer
Chief Financial Officer
--
--
Prof. Itzhak Kelson
Prof. Itzhak Kelson
Chief Physics Officer
Chief Physics Officer
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Oramed Pharmaceuticals Inc
16.59%
Sofer (Uzi)
13.54%
Avruch (Michael)
1.82%
Hightower Advisors, LLC
0.81%
Keisari (Yona)
0.59%
Other
66.64%
Shareholders
Shareholders
Proportion
Oramed Pharmaceuticals Inc
16.59%
Sofer (Uzi)
13.54%
Avruch (Michael)
1.82%
Hightower Advisors, LLC
0.81%
Keisari (Yona)
0.59%
Other
66.64%
Shareholder Types
Shareholders
Proportion
Corporation
16.59%
Individual Investor
16.20%
Investment Advisor
1.50%
Investment Advisor/Hedge Fund
0.62%
Hedge Fund
0.11%
Bank and Trust
0.04%
Other
64.94%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
54
29.36M
34.67%
+14.03M
2025Q1
56
19.44M
23.97%
-491.93K
2024Q4
55
19.31M
27.55%
-2.82M
2024Q3
59
19.28M
27.51%
-4.37M
2024Q2
62
19.31M
27.55%
-4.87M
2024Q1
65
19.84M
28.32%
-4.33M
2023Q4
137
22.06M
31.83%
-24.51M
2023Q3
140
32.52M
46.94%
-14.56M
2023Q2
146
33.02M
48.83%
-14.67M
2023Q1
145
32.68M
48.37%
-16.77M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Oramed Pharmaceuticals Inc
14.11M
16.66%
+14.11M
--
Apr 24, 2025
Sofer (Uzi)
11.52M
13.6%
--
--
Mar 01, 2025
Avruch (Michael)
1.55M
1.83%
+2.71K
+0.17%
Mar 01, 2025
Hightower Advisors, LLC
230.70K
0.27%
--
--
Mar 31, 2025
Keisari (Yona)
504.27K
0.6%
+781.00
+0.16%
Mar 01, 2025
HoyleCohen, LLC
269.09K
0.32%
--
--
Jun 30, 2024
Kovitz Investment Group Partners, LLC
226.32K
0.27%
+194.06K
+601.44%
Mar 31, 2025
Levin Capital Strategies, L.P.
222.51K
0.26%
-92.00K
-29.25%
Mar 31, 2025
Milch (David Mark)
88.74K
0.1%
-2.00K
-2.20%
Mar 01, 2025
Gat (Amnon)
68.47K
0.08%
--
--
Mar 01, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
